Skip to main content

Table 6 Multivariate regression analysis: impact of patient covariates and valve prosthesis on patient early term survival (30-day)

From: Sutureless Biological Aortic Valve Replacement (Su-AVR) in Redo operations: a retrospective real-world experience report of clinical and echocardiographic outcomes

 

Hazard ratio

Standard error

95% CI

P value

Perceval

1.22

1.32

0.14 – 10.25

0.855

Age

1.03

0.04

0.95 – 1.10

0.475

Gender

0.72

0.74

0.10 – 5.40

0.752

BMI

0.95

0.10

0.76 – 1.17

0.610

Smoking

1.43

1.17

0.29 – 7.14

0.663

LVEF

0.95

0.04

0.88 – 1.02

0.147